Artificial Intelligence is steadily becoming a practical tool in healthcare, offering solutions to some of the field’s most persistent challenges. One area seeing significant benefits is AI in Pathology, where technology is helping pathologists manage increasing workloads while improving the accuracy and efficiency of diagnostics.
During the Annual Congress of the French Society of Pathology in 2024, Tribun Health and Ibex shared how they are integrating AI-powered Digital Pathology into routine practice. In a session titled "Optimizing Diagnostics: The Integration of AI with Tribun Health and Ibex," Celine Riou, AI Product Manager at Tribun Health, and Dr. Geraldine Sebag, Pathologist at Ibex, presented real-world applications of these tools and the meaningful impact they’re having on diagnostic workflows.
Tribun Health has built a platform that doesn’t just digitize pathology but optimizes every aspect of the process. CaloPix®, their flagship product, integrates seamlessly into existing laboratory workflows to support image management, annotation, and long-term storage. What sets it apart is its ability to incorporate third-party AI algorithms, enabling labs of all sizes to access cutting-edge tools like those from Ibex.
The Tribun Health platform is web-based, secure, and approved for use in major markets. With connectivity at its core, CaloPix® is designed to adapt to the specific needs of laboratories while ensuring scalability for future growth.
Dr. Sebag showcased how Ibex's AI-powered tools augment the diagnostic process while maintaining the pivotal role of pathologists. Ibex’s solutions address modern challenges such as a shortage of pathologists, increasing cancer incidences, and diagnostic complexities.
Designed "by pathologists for pathologists," Ibex leverages over 10 million annotated slides to deliver exceptional accuracy and efficiency. Its algorithms, validated through extensive studies, demonstrate remarkable improvements in workflow optimization, diagnostic precision, and reduced turnaround times. Whether identifying prostate cancer, grading Gleason scores, or detecting gastric cancer biomarkers, Ibex sets a new benchmark in pathology.
The integration of AI algorithms within CaloPix® delivers unparalleled benefits:
This collaboration extends to various cancer types, including prostate, breast, and gastric cancers. For instance, Ibex's gastric cancer solution not only detects high-grade lesions but also identifies H. Pylori, reducing the reliance on additional staining methods.
Tribun Health and Ibex embody the synergy of AI and human expertise, driving a transformative shift in pathology. By reducing diagnostic errors, increasing reproducibility, and supporting pathologists in their decision-making, these innovations significantly enhance patient care.
As Dr. Sebag aptly noted, “AI doesn’t replace the pathologist—it guides and supports them, ensuring precision and efficiency in diagnostics.”
🎥 Curious to learn more? Watch the full recording of the mini-symposium and see AI in action.
Click here to access the session!